Applied Clinical Trials-09-01-2001

Inside IT
Applied Clinical Trials

September 01, 2001

CDISC has broad support for its fledgling standard whose evolution is critical to the acceleration of technology adoption in clinical trials.

View from Washington
Applied Clinical Trials

September 01, 2001

As the public clamors for early access to promising new drugs, sponsors worry about the consequences of experimental therapy conducted outside of controlled trials.

View from Brussels
Applied Clinical Trials

September 01, 2001

Patients, research companies, and regulatory authorities may all benefit from proposed changes to current pharmaceutical legislation, but the proposals will provoke much debate.

Notes from the Field
Applied Clinical Trials

September 01, 2001

Readers share their experience

Media Review
Applied Clinical Trials

September 01, 2001

Michael R. Hamrell, PhD, Ed., (Drugs and Pharmaceutical Sciences, volume 104, Marcel Dekker, New York, 1999), 224 pages, hardcover, ISBN 0-8247-0309-X, $135.

Notes from the Field
Applied Clinical Trials

September 01, 2001

Readers share their experience

Feature Article
Applied Clinical Trials

September 01, 2001

Combining the principles of adult learning with the advantages of Web technology can engage participants in important investigator meetings.

Feature Article
Applied Clinical Trials

September 01, 2001

New systems of ethical oversight for randomized controlled trials could ease the problems caused by increasingly cumbersome restrictions.

Feature Article
Applied Clinical Trials

September 01, 2001

EN ISO/IEC 17025 is more evidence that international standards are evolving to keep pace with technology and improve the performance of accredited central laboratories.

Meet the EAB
Applied Clinical Trials

September 01, 2001

As well as being a committed European, Domenico Criscuolo is a powerful supporter of the Italian clinical research community.

Feature Article
Applied Clinical Trials

September 01, 2001

A creative mobile monitoring model could help sponsors tap the potential of southern Europe (and Mexico) as areas for clinical research.